Mentor consent decree vacated
This article was originally published in The Gray Sheet
Executive Summary
Dallas federal court finds Irving, Texas facility to be in compliance with FDA GMP requirements, Santa Barbara company announces Sept. 8. Mentor entered into the consent decree in 1998. The enforcement action related to a breast implant production site (1"The Gray Sheet" May 11, 1998, p. 16)...
You may also be interested in...
Mentor Consent Decree Mandates Facility Recertification By Consultant
Mentor plans to complete by this fall the recertification of its breast implant production facility.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.